Send to

Choose Destination
See comment in PubMed Commons below
Am J Cardiol. 2013 Oct 1;112(7):1051-3. doi: 10.1016/j.amjcard.2013.05.043. Epub 2013 Aug 1.

Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease.

Author information

Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy. Electronic address:


A man with severe rheumatic trivalvular disease was treated with surgical implantation of mechanical aortic and mitral prostheses at the age of 30 years and tricuspid bioprosthesis at the age of 50 years. At 61 years of age, he developed severe symptomatic tricuspid regurgitation due to bioprosthesis degeneration and was judged at very high risk for a third surgical approach. The investigators describe the successful transfemoral positioning of a 29-mm Edwards SAPIEN XT percutaneous valve inside the degenerated tricuspid prosthesis, with excellent acute results and no major complications. In conclusion, percutaneous valve-in-valve treatment of degenerated bioprostheses is feasible by the transfemoral route and may be of assistance in very selected patients at high surgical risk.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center